Background
William Frances Silvia was sentenced to death for murdering his estranged wife, Patricia Silvia, and was also convicted of attempting to murder her mother. The Florida Supreme Court affirmed his convictions and sentence on direct appeal. In 2012, after a detailed judicial colloquy, Silvia validly waived postconviction proceedings and discharged collateral counsel, acknowledging that the waiver permanently surrendered his ability to benefit from later changes in the law and made him eligible for a death warrant.
After Governor Ron DeSantis scheduled Silvia’s execution for August 18, 2026, appointed counsel filed a successive postconviction motion. Silvia argued that counsel could not effectively represent him while simultaneously handling another active death warrant and that a reported nationwide shortage of etomidate, the first drug in Florida’s lethal-injection protocol, could prevent the Department of Corrections from executing him in the same manner as other prisoners. The postconviction court summarily denied both claims.
The Court’s Holding
The Florida Supreme Court affirmed. It held that Silvia’s valid waiver permanently barred collateral attacks on his judgment and sentence, notwithstanding a 2022 rule amendment requiring appointment of counsel for prisoners who had previously discharged counsel. Because the State agreed that claims limited to the execution process could be considered, however, the Court addressed Silvia’s two claims on their merits.
The Court held that appointing Capital Collateral Regional Counsel satisfied Silvia’s statutory right to competent postconviction counsel. Florida law does not create a right to effective assistance of postconviction counsel, and the office did not become incompetent merely because it represented two prisoners under active death warrants. Silvia received notice, an opportunity to be heard, and access to the courts, while the Governor retained discretion over the warrant’s timing.
The Court also held that Silvia’s etomidate claim was speculative and did not warrant an evidentiary hearing. The industry report on which he relied did not address the Department of Corrections or its drug supply, and the Department was presumed to follow its lethal-injection protocol. The Court affirmed the denial of postconviction relief, denied a stay and oral argument, directed the mandate to issue immediately, and barred rehearing.
Key Takeaways
- A valid waiver of capital postconviction proceedings permanently bars later collateral attacks on the judgment and sentence, even though current rules require appointment of collateral counsel.
- Florida’s statutory right to postconviction counsel guarantees representation by qualified counsel, not a claim for constitutionally effective assistance.
- General reports of a drug shortage, without allegations showing a deficiency in the Department of Corrections’ own supply or an expected protocol violation, are too speculative to require an evidentiary hearing.
Why It Matters
The decision reinforces the continuing effect of a death-row prisoner’s knowing and voluntary waiver of postconviction review while recognizing a narrow path for claims directed solely at the execution process. Even those claims must be pleaded with concrete facts rather than fears about what prison officials might do.
For warrant-stage litigation, the ruling also confirms that overlapping representation and an expedited schedule do not by themselves establish denial of due process, access to courts, or a statutory right to counsel.